San Francisco, California, United States
Ending the threat of age-related disease is a bold goal. It is also what the Buck Institute has been working on for 25 years. Reaching it requires a deep, discipled understanding of the biology of aging and the patience to translate it responsibly into human benefit. When those conditions are met, longer life can also mean better life. That belief guides my work as President and CEO of the Buck Institute for Research on Aging, where our focus is clear: build rigorous, implementable science that helps people enjoy their lives at 95 as much as they do at 25. My career has been dedicated to understanding how aging actually works. Much of my work has focused on the immune system, where aging shows up early through chronic inflammation and declining immune adaptive responses. Using human cells, animal models, and clinical settings, my work has helped establish chronic inflammation as a central driver of age-related disease. From virology, to immune aging to metabolism and nutrition, I have published over 300 peer-reviewed studies and worked across academia, biotech, philanthropy, and policy to move aging research from theory into practice. And I care deeply about where this field is heading. Longevity advice will only succeed if it is grounded in data, guided by integrity, and translated responsibly. The goal is to extend the healthy years of life, so people can remain active, independent, and thriving for as long as possible. If you are building, funding, or studying the future of longevity and want it to stand the test of time, you are in the right place. Follow along to engage with credible aging science, real progress, and the work required to end age-related disease.